Harte Hanks (HHS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
Chairman welcomed shareholders, introduced board members, and outlined meeting procedures.
Proxy Statement and meeting materials were distributed to shareholders in advance.
Quorum was confirmed, allowing the meeting to proceed.
Board and executive committee updates
Newest board member, Elizabeth Ross, appointed in January 2024, was introduced.
Backgrounds of all directors were referenced as available in the Proxy Statement.
Shareholder proposals
Three proposals were presented: election of four directors, advisory vote on executive compensation (Say on Pay), and ratification of independent auditors.
No questions were raised by shareholders on any of the proposals.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Harte Hanks
- Q2 2026 saw a net loss of $5.0M and a pending acquisition by Star Equity Holdings.HHS
Q2 2026 - Revenue fell 10.3% and net loss widened, but strong liquidity supports a positive outlook.HHS
Q1 2026 - Operational improvements, governance enhancements, and key votes position the company for growth.HHS
Proxy filing - Positive EBITDA and improved net results in FY 2025 despite lower revenue and segment declines.HHS
Q4 2025 - Shareholders to vote on board, executive pay, and auditor as company targets growth and innovation.HHS
Proxy Filing - Beneficial ownership update adds Rosenbachs as 26.26% holders for 2025 meeting.HHS
Proxy Filing - Q3 2025 revenue dropped 17% with net loss, but cost controls and new deals support outlook.HHS
Q3 2025 - Q3 revenue up 1.1% YoY; profit metrics declined; Q4 revenue expected to contract.HHS
Q3 2024 - Q2 net loss of $27.8M from pension charge; Sales Services surged, cash strong, no debt.HHS
Q2 2024